Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute ...

Combining immunotherapy drugs with arthritis anti-inflammatory pills to blitz aggressive cancers has never been tried before ...

Long-term use of NSAIDs has been linked to a reduced risk of developing dementia due to their anti-inflammatory properties. A ...

Updated results of an Australian trial which used liquid biopsies to guide colon cancer treatment has confirmed no compromise ...

Engaging in physical activity is a strategy that may enable patients to live longer after their cancer diagnosis and live a length of life that begins to approximate the national norms,” said Justin C ...

The interaction of celecoxib and rofecoxib with warfarin was studied. Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional ...

Less than 3% of all prescriptions involved opioids, the study found, and more than 90% of players never received an opioid for their pain.